Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Clinical Studies
  • View item
  • Home
  • ICR Divisions
  • Clinical Studies
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The UK plasma based molecular profiling of advanced breast cancer to inform therapeutic choices (plasmamatch) trial: a multiple parallel cohort, open-label, multi-centre phase IIa clinical trial aiming to provide proof of principle efficacy for designated targeted therapies in patients with advanced breast cancer where the targetable mutation is identified through ctDNA screening (CRUK/15/010)

Thumbnail
View/Open
Accepted version (405.3Kb)
Accepted version (330.3Kb)
Accepted version (282.2Kb)
Date
2017-05-08
ICR Author
Kernaghan, Sarah
Morden, James Peter
Bliss, Judith
Snowdon, Claire
Author
Bliss, J
Kernaghan, S
Fribbens, C
Stevenson, L
Morden, J
Snowdon, C
Macpherson, I
Wardley, A
Roylance, R
Baird, R
Show allShow less
Type
Other
Metadata
Show full item record
URI
https://repository.icr.ac.uk/handle/internal/873
Collections
  • Clinical Studies
Subject
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
Research team
Clinical Trials & Statistics Unit
Language
eng
License start date
2017-05-08
Citation
TRIALS, 2017, 18 pp. ? - ? (1)
Publisher
BIOMED CENTRAL LTD

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.